| scholarly article | Q13442814 |
| P50 | author | Fausto Catena | Q100647833 |
| P2093 | author name string | Luca Ansaloni | |
| Federico Coccolini | |||
| Maria Carla Valli | |||
| Simona Cima | |||
| Giulia Montori | |||
| Marco Ceresoli | |||
| Arianna Heyer | |||
| Gabriela E Nita | |||
| P2860 | cites work | Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial | Q60716217 |
| Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial | Q62628533 | ||
| The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients | Q62712082 | ||
| Early cancer of the stomach | Q66988660 | ||
| Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study | Q69485318 | ||
| Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients | Q72633352 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study | Q74463807 | ||
| Extended lymph-node dissection for gastric cancer | Q74629358 | ||
| Can sentinel node biopsy indicate rational extent of lymphadenectomy in gastric cancer surgery? Fundamental and new information on lymph-node dissection | Q77751403 | ||
| Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial | Q79450404 | ||
| Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial | Q79792451 | ||
| Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis | Q80019806 | ||
| Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501 | Q80204606 | ||
| A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results | Q81098099 | ||
| D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer | Q81724011 | ||
| Nodal dissection for patients with gastric cancer: a randomised controlled trial | Q83017438 | ||
| Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer | Q83052119 | ||
| Neoadjuvant treatment of gastric cancer with peritoneal dissemination | Q83169040 | ||
| Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate? | Q83903250 | ||
| Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy | Q83903423 | ||
| Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 | ||
| Patterns of response after preoperative treatment in gastric cancer | Q84591595 | ||
| Positive peritoneal washing cytology in multiple cavities can predict poor prognosis of advanced gastric cancer patients | Q84763521 | ||
| A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection | Q84981772 | ||
| Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis | Q86377243 | ||
| Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial | Q87416761 | ||
| Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis in | Q88081208 | ||
| Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection | Q40794191 | ||
| Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG). | Q40797057 | ||
| Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database | Q41512455 | ||
| Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer | Q41750297 | ||
| Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). | Q42649289 | ||
| Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis | Q42670286 | ||
| Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial | Q42695547 | ||
| Three-step method for systematic lymphadenectomy in gastric cancer surgery using the 'curettage and aspiration dissection technique' with Peng's multifunctional operative dissector | Q42984626 | ||
| Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery | Q43288249 | ||
| Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 | ||
| Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis | Q43479667 | ||
| Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer | Q43620764 | ||
| Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome | Q44019896 | ||
| Super-extended (D3) lymphadenectomy in advanced gastric cancer. | Q44678400 | ||
| Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma | Q44978576 | ||
| Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial | Q44980504 | ||
| Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer | Q45119980 | ||
| Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion | Q45288550 | ||
| Spleen-preserving splenic hilar lymphadenectomy at the time of gastrectomy for cancer: technical feasibility and early results | Q46313380 | ||
| An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach | Q46649725 | ||
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center | Q48831086 | ||
| Feasibility of Gastrectomy with Standard Lymphadenectomy for Patients Over 85 Years Old with Gastric Cancer. | Q50575996 | ||
| Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. | Q50999355 | ||
| Japanese Classification of Gastric Carcinoma - 2nd English Edition - | Q51050338 | ||
| Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer: a meta-analysis of the literature. | Q53134672 | ||
| Selection of patients with gastric adenocarcinoma for laparoscopic staging. | Q53557163 | ||
| Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. | Q53851087 | ||
| A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. | Q53879165 | ||
| Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer. | Q54321983 | ||
| Prognostic significance of intraperitoneal cancer cells in gastric carcinoma: detection of cytokeratin 20 mRNA in peritoneal washes, in addition to detection of carcinoembryonic antigen. | Q54649837 | ||
| 7th Edition of the AJCC Cancer Staging Manual: Stomach | Q55053470 | ||
| Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer | Q57259796 | ||
| Peritoneal carcinomatosis | Q58766340 | ||
| Adenocarcinomas of the Esophagogastric Junction Are More Likely to Respond to Preoperative Chemotherapy than Distal Gastric Cancer | Q60056771 | ||
| Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus | Q24202957 | ||
| Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach | Q24247667 | ||
| Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention | Q26849435 | ||
| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 | ||
| Lapatinib plus paclitaxel versus paclitaxel alone in the second-line treatment of HER2-amplified advanced gastric cancer in Asian populations: TyTAN--a randomized, phase III study | Q27853010 | ||
| Comparison of international guidelines on the accompanying therapy for advanced gastric cancer: reasons for the differences | Q28086772 | ||
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study | Q29620647 | ||
| Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial | Q29620687 | ||
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial | Q29620917 | ||
| Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan | Q30719628 | ||
| Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: a single western center experience. | Q34009620 | ||
| Significance of the lymph nodes in the 7th station in rational dissection for metastasis of distal gastric cancer with different T categories | Q34130190 | ||
| Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer | Q34255463 | ||
| Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer | Q34390124 | ||
| Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials | Q34478555 | ||
| Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. | Q34488692 | ||
| Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. | Q34504614 | ||
| Preoperative versus postoperative chemoradiotherapy for rectal cancer | Q34552041 | ||
| Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response | Q34570217 | ||
| Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials | Q34590558 | ||
| Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer | Q34618494 | ||
| Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial | Q34627996 | ||
| Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review | Q34631121 | ||
| Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 | ||
| Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial | Q34634936 | ||
| Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection | Q34638268 | ||
| Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials | Q34658004 | ||
| Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer | Q34660654 | ||
| Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial | Q34928467 | ||
| Current status of novel agents in advanced gastroesophageal adenocarcinoma | Q34962039 | ||
| Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy. | Q34962091 | ||
| Sentinel node navigation surgery for gastric cancer: Overview and perspective | Q34991959 | ||
| Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study | Q34996992 | ||
| Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials? | Q35031712 | ||
| Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma | Q35034753 | ||
| Laparoscopic vs open total gastrectomy for gastric cancer: a meta-analysis. | Q35059454 | ||
| Robotic versus open gastrectomy for gastric cancer: a meta-analysis | Q35061416 | ||
| Laparoscopic versus open total gastrectomy for gastric cancer: an updated meta-analysis | Q35099659 | ||
| Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer | Q35152348 | ||
| Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer | Q35476298 | ||
| TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG). | Q35700920 | ||
| Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study). | Q35981433 | ||
| Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer | Q36001259 | ||
| Effects of neoadjuvant intraperitoneal/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer | Q36151519 | ||
| Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy | Q36544341 | ||
| Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group | Q36619190 | ||
| The role of palliative radiation therapy in symptomatic locally advanced gastric cancer. | Q36659711 | ||
| Prediction of cancer incidence and mortality in Korea, 2013. | Q36775112 | ||
| The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas | Q37217887 | ||
| Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects | Q37724647 | ||
| Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis | Q37742318 | ||
| Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies. | Q37831541 | ||
| How many lymph nodes should be assessed in patients with gastric cancer? A systematic review | Q38034917 | ||
| Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial | Q38099726 | ||
| Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis | Q38122908 | ||
| The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art. | Q38201470 | ||
| A meta-analysis of robotic versus laparoscopic gastrectomy for gastric cancer | Q38208757 | ||
| The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review | Q38213679 | ||
| Update on treatment of gastric cancer | Q38218365 | ||
| Current status of management of malignant disease: current management of gastric cancer | Q38319561 | ||
| Controversies in the treatment of local and locally advanced gastric and esophageal cancers. | Q38445730 | ||
| Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis | Q38456068 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1139-59 | |
| P577 | publication date | 2016-01-21 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Advanced gastric cancer: What we know and what we still have to learn | |
| P478 | volume | 22 |
| Q37530507 | CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study |
| Q52565789 | CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer. |
| Q90579936 | DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1 |
| Q38767113 | Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer |
| Q36329068 | Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer |
| Q37061127 | Inductions of Caspase-, MAPK- and ROS-dependent Apoptosis and Chemotherapeutic Effects Caused by an Ethanol Extract of Scutellaria barbata D. Don in Human Gastric Adenocarcinom Cells |
| Q33895603 | Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis |
| Q47096468 | Preventive effect of Oenothera rosea on N-methyl-N-nitrosourea-(NMU) induced gastric cancer in rats. |
| Q90587428 | Psychological effects of advanced care on patients received endoscopic gastric cancer resection |
| Q89535788 | Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology |
| Q90402831 | Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 g |
| Q38689450 | The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. |
| Q98159020 | Tumor suppressor role of miR-876-5p in gastric cancer |
Search more.